Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):771-779. doi: 10.1016/j.ijrobp.2021.09.047. Epub 2021 Oct 5.
Diffuse intrinsic pontine gliomas (DIPGs) arise in the pons and are the leading cause of death from brain tumors in children. DIPGs are routinely treated with radiation therapy, which temporarily improves neurological symptoms but generally fails to achieve local control. Because numerous clinical trials have not improved survival from DIPG over standard radiation therapy alone, there is a pressing need to evaluate new therapeutic strategies for this devastating disease. Vascular damage caused by radiation therapy can increase the permeability of tumor blood vessels and promote tumor cell death.
To investigate the impact of endothelial cell death on tumor response to radiation therapy in DIPG, we used dual recombinase (Cre + FlpO) technology to generate primary brainstem gliomas which lack ataxia telangiectasia mutated (Atm) in the vasculature.
Here, we show that Atm-deficient tumor endothelial cells are sensitized to radiation therapy. Furthermore, radiosensitization of the vasculature in primary gliomas triggered an increase in total tumor cell death. Despite the observed increase in cell killing, in mice with autochthonous DIPGs treated with radiation therapy, deletion of Atm specifically in tumor endothelial cells failed to improve survival.
These results suggest that targeting the tumor cells, rather than endothelial cells, during radiation therapy will be necessary to improve survival among children with DIPG.
弥漫性内在脑桥神经胶质瘤(DIPG)发生于脑桥,是儿童脑瘤死亡的主要原因。DIPG 通常采用放射疗法治疗,该疗法可暂时改善神经症状,但通常无法实现局部控制。由于许多临床试验并未使 DIPG 的生存率超过单纯标准放射疗法,因此迫切需要评估针对这种毁灭性疾病的新治疗策略。放射疗法引起的血管损伤会增加肿瘤血管的通透性并促进肿瘤细胞死亡。
为了研究内皮细胞死亡对 DIPG 中放射疗法反应的影响,我们使用双重组酶(Cre+FlpO)技术生成原发性脑桥神经胶质瘤,这些肿瘤在血管中缺乏共济失调毛细血管扩张突变(Atm)。
在这里,我们表明 Atm 缺陷型肿瘤内皮细胞对放射疗法敏感。此外,原发性神经胶质瘤中血管的放射增敏作用会导致总肿瘤细胞死亡增加。尽管观察到细胞杀伤增加,但在接受放射疗法治疗的具有同源性 DIPG 的小鼠中,特异性删除肿瘤内皮细胞中的 Atm 并不能提高存活率。
这些结果表明,在放射疗法期间针对肿瘤细胞而不是内皮细胞进行靶向治疗将是提高 DIPG 患儿生存率的必要条件。